{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:49Z","timestamp":1791230749841,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yexmp.2026.105042","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:00:04Z","timestamp":1775840404000},"page":"105042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Indoleamine 2,3-dioxygenase 1 expression predicts cholangiocarcinoma patient survival"],"prefix":"10.1016","volume":"146","author":[{"given":"Mallika","family":"Naeklang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasaya","family":"Dokduang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Prajumwongs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poramate","family":"Klanrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arporn","family":"Wangwiwatsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisana","family":"Namwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attapol","family":"Titapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakasit","family":"Sa-Ngiamwibool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharin","family":"Loilome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yexmp.2026.105042_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12123093","article-title":"Allred scoring of ER-IHC stained whole-slide images for hormone receptor status in breast carcinoma","volume":"12","author":"Ahmad Fauzi","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.yexmp.2026.105042_bb0010","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2017.6834","article-title":"Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis","author":"Asghar","year":"2017","journal-title":"Oncol. Lett."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105042_bb0015","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1158\/1078-0432.CCR-16-2272","article-title":"First-in-human phase i study of the oral inhibitor of indoleamine 2,3-Dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies","volume":"23","author":"Beatty","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105042_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105670","article-title":"Expression of the large amino acid transporter SLC7A5\/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma","volume":"153","author":"Branchi","year":"2024","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2026.105042_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114785","article-title":"Breakdown of chemo-immune resistance by a TDO2-targeted Pt(IV) prodrug via attenuating endogenous Kyn-AhR-AQP4 metabolic circuity and TLS-promoted genomic instability","volume":"193","author":"Chen","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105042_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2\u2013KYN\u2013AhR pathway for cancer immunotherapy \u2013 challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yexmp.2026.105042_bb0040","first-page":"1","article-title":"Pancancer analysis of revealed TDO2 as a biomarker of prognosis and immunotherapy","volume":"2022","author":"Cui","year":"2022","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105042_bb0045","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105042_bb0050","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1111\/jcmm.15176","article-title":"A comprehensive analysis of IDO1 expression with tumour-infiltrating immune cells and mutation burden in gynaecologic and breast cancers","volume":"24","author":"Feng","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105042_bb0055","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cells12060862","article-title":"Revealing the heterogeneity of the tumor ecosystem of cholangiocarcinoma through single-cell transcriptomics","volume":"12","author":"Golino","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105042_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv. Anat. Pathol."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105042_bb0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jcp.2005.034447","article-title":"Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays","volume":"60","author":"Henriksen","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2026.105042_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100934","article-title":"Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer","volume":"44","author":"Hoffmann","year":"2023","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.yexmp.2026.105042_bb0075","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/cancers14112756","article-title":"The role of indoleamine 2, 3-dioxygenase 1 in regulating tumor microenvironment","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105042_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1004220","article-title":"Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand","volume":"12","author":"Intarawichian","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105042_bb0090","article-title":"MRNA-delivery of IDO1 suppresses t cell-mediated autoimmunity","volume":"5","author":"Kenney","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105042_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ceb.2006.08.008","article-title":"CEACAMs: their role in physiology and pathophysiology","volume":"18","author":"Kuespert","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.yexmp.2026.105042_bb0100","article-title":"TDO2 promotes the EMT of hepatocellular carcinoma through Kyn-AhR pathway","volume":"10","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2026.105042_bb0105","article-title":"Metabolic reprogramming in the post-metastatic tumor microenvironment: multi-omics insights into determinants of immunotherapy response","volume":"16","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105042_bb0110","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.immuni.2021.10.005","article-title":"Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses","volume":"54","author":"Lightman","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105042_bb0115","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1038\/s41598-017-17175-7","article-title":"CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma","volume":"7","author":"Loosen","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105042_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cas.15182","article-title":"Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer","volume":"113","author":"Miyazaki","year":"2022","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105042_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105042_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000870","article-title":"Preclinical investigations and a first-in-human phase i trial of m4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors","volume":"8","author":"Naing","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105042_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/ol.2022.13493","article-title":"Prognostic implications of immune classification using IDO1 expression in extrahepatic bile duct carcinoma","volume":"24","author":"Noh","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexmp.2026.105042_bb0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2018.04.058","article-title":"Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: a retrospective cohort study","volume":"54","author":"Ohira","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.yexmp.2026.105042_bb0145","article-title":"Preparation of formalin-fixed paraffin-embedded tissue cores for both RNA and DNA extraction","volume":"114","author":"Patel","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105042_bb0150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","article-title":"Metabolic reprogramming in cholangiocarcinoma","volume":"77","author":"Raggi","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexmp.2026.105042_bb0155","article-title":"Updated cholangiocarcinoma incidence trends and projections in Thailand by region based on data from four population-based cancer registries","volume":"35","author":"Sahat","year":"2025","journal-title":"Lancet Reg. Health - Southeast Asia"},{"issue":"13_Supplement","key":"10.1016\/j.yexmp.2026.105042_bb0165","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1158\/1538-7445.AM2018-4723","article-title":"Abstract 4723: targeting the IDO and TDO pathway through inhibition of the aryl hydrocarbon receptor","volume":"78","author":"Tchaicha","year":"2018","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105042_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20473","article-title":"Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy","volume":"9","author":"Titapun","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105042_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010387","article-title":"How the AHR became important in cancer: the role of chronically active AHR in cancer aggression","volume":"22","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105042_bb0180","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s12935-021-02228-9","article-title":"Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway","volume":"21","author":"Wu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105042_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12943-024-02164-y","article-title":"Molecular mechanisms and therapeutic significance of tryptophan metabolism and signaling in cancer","volume":"23","author":"Yan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexmp.2026.105042_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116457","article-title":"Serum targeted metabolomics uncovering specific amino acid signature for diagnosis of intrahepatic cholangiocarcinoma","volume":"252","author":"Zhang","year":"2025","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:22:22Z","timestamp":1781684542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S0014480026000213"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105042","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indoleamine 2,3-dioxygenase 1 expression predicts cholangiocarcinoma patient survival","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105042"}}